Gullaksen, S. E., Skavland, J., Gavasso, S., Tosevski, V., Warzocha, K., Dumrese, C. ... Gjertsen, B. T. (2017). Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib. Haematologica, 102. (8), 1361-1367. doi: 10.3324/haematol.2017.167080
Gullaksen, Stein Erik, et al. "Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib." Haematologica, vol. 102, no. 8, 2017, pp. 1361-1367. https://doi.org/10.3324/haematol.2017.167080
Gullaksen, Stein Erik, Jørn Skavland, Sonia Gavasso, Vinko Tosevski, Krzysztof Warzocha, Claudia Dumrese, Augustin Ferrant, et al. "Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib." Haematologica 102, no. 8 (2017): 1361-1367. https://doi.org/10.3324/haematol.2017.167080
Gullaksen, S. E., et al. (2017) 'Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib', Haematologica, 102(8), pp. 1361-1367. doi: 10.3324/haematol.2017.167080
Gullaksen SE, Skavland J, Gavasso S, Tosevski V, Warzocha K, Dumrese C, and sur.. Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib. Haematologica [Internet]. 2017 August [cited 2024 November 30];102(8):1361-1367. doi: 10.3324/haematol.2017.167080
S. E. Gullaksen, et al., "Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib", Haematologica, vol. 102, no. 8, pp. 1361-1367, August 2017. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:821605. [Accessed: 30 November 2024]